Strong Revenue Growth
Concentra reported a 17% year-over-year revenue growth in Q3 2025, reaching $572.8 million, with a 10.6% increase excluding the Nova acquisition.
Increase in Patient Visits
Total patient visits increased by 9.2%, with workers' compensation visits up by 9.8% and employer services visit volumes increasing by 8.9% from the previous year.
Adjusted EBITDA Improvement
Adjusted EBITDA grew by 17.1% to $118.9 million, with the margin slightly increasing from 20.7% in Q3 2024 to 20.8% in Q3 2025.
Successful Integrations
Integration of the Nova acquisition and Pivot Onsite Innovations advanced well, with over 85% of operational and back-office synergies captured.
Positive Outlook on M&A Strategy
Company plans to continue successful acquisition strategy focusing on smaller practices with an average acquisition multiple of less than 3x EBITDA post-synergy.